PORTLAND, Oregon and PUNE, India, February 8, 2017 /PRNewswire/ --
A new report published by Allied Market Research, titled, "Preimplantation Genetics Diagnosis Market - Global Opportunity Analysis and Industry Forecast, 2014-2022", projects that in moderate growth scenario the potential market for preimplantation genetic diagnosis market size was valued $79 million in 2015, and is expected to reach approximately $121 million by 2022, registering a CAGR of 6.14% from 2016 to 2022.Continue Reading
Summary of the Preimplantation Genetics Diagnosis (PGD) Market Report can be accessed on the website at: https://www.alliedmarketresearch.com/preimplantation-genetic-diagnosis-market
Around 30 to 60% of the human embryos have chromosomal abnormalities. They usually occur in women aged 40 and above. Moreover, chromosomal abnormalities are also seen in working women due to the hectic lifestyle patterns which increase the demand of various diagnostic procedures including PGD.
"People are anxious over potential harmful effects related to chromosomal, genetic, and hereditary, leads to infertility-related problems such as PCOS and low sperm count disorders." says Hemali Narkhede, Manager, Healthcare Research at Allied Market Research "PGD helps in preventing inheritance of diseases and thereby eliminating the chances of pregnancy termination," she further added.
According to the World Health Organization (WHO), around 48.5 million couples worldwide were unable to conceive child in 2010. Furthermore, increasing risk of fatal genetic, hereditary, and chromosomal diseases such as duchenne muscular dystrophy, down syndrome, cystic fibrosis, triploidy, and thalassemia promote patients to opt for PGD thereby, boosting the market growth worldwide. Furthermore, increase in awareness about innovative and advanced application of PGD in the developing countries such as China and India offers enormous opportunities for the market growth. Rise in awareness about the various genetic disorders and chromosomal abnormalities have increased the demand of diagnostic procedures including PGD.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Geographically, Europe holds the highest potential to generate major revenue of the global market accounting for about 31.8% share in 2015. While Asia-Pacific is the fastest growing region registering a CAGR of 6.7%.
Key findings of the study:
The key market players are F. Hoffmann-La Roche AG, Reprogenetics, LLC, Genea Limited, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Genesis Genetics Ltd., and Reproductive Genetics Innovations LLC.
Summary of similar reports can be viewed at: https://www.alliedmarketresearch.com/life-sciences/diagnostic-and-biotech-market-report
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
|SOURCE Allied Market Research|
Copyright©2017 PR Newswire.
All rights reserved